ONCY - Oncolytics Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCY is currently covered by 1 analysts with an average price target of $4.29. This is a potential upside of $3.42 (393.1%) from yesterday's end of day stock price of $0.87.

Oncolytics Biotech's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of ONCY is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ONCY is $5, Lowest price target is $5, average price target is $5.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 21-May-2025. First documented stock forecast 17-Feb-2021.

Best performing analysts who are covering ONCY - Oncolytics Biotech:

John Newman Patrick Trucchio

Currently out of the existing stock ratings of ONCY, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.98 (390.20%)

$5

2 months 22 days ago
(21-May-2025)

0/9 (0%)

$4.58 (1090.48%)

Buy

$5

$3.98 (390.20%)

$5

2 years 1 months 20 days ago
(23-Jun-2023)

0/3 (0%)

$2.26 (82.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCY (Oncolytics Biotech) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ONCY (Oncolytics Biotech) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on ONCY (Oncolytics Biotech) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on ONCY (Oncolytics Biotech)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ONCY

Which analyst is the currently most bullish on ONCY (Oncolytics Biotech)?

Patrick Trucchio with highest potential upside - $3.98

Which analyst is the currently most reserved on ONCY (Oncolytics Biotech)?

John Newman with lowest potential downside - $3.98

Oncolytics Biotech in the News

Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the management team bring expertise in progressing clinical programs and executing successful biotech transactions Translational data further elucidate pelareorep’s mechanism of action and ability to prime the tumor microenvironment for treatment...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?